Healthcare worker Dismus Mwalukwanda is on the front line of the battle against malaria. Saving lives is his priority.

Explaining Chagas disease through the stories of patients in Latin America.

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Parents and doctors can help children understand rare diseases like TSC and SJIA with the help of cartoon dogs and comic book superheroes.